Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion description "[Post-GVAX T-cell infiltration and aggregate formation resulted in the upregulation of immunosuppressive regulatory mechanisms, including the PD-1-PD-L1 pathway, suggesting that patients with vaccine-primed PDAC may be better candidates than vaccine-na�ve patients for immune checkpoint and other immunomodulatory therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion evidence source_evidence_literature NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion SIO_000772 24942756 NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion wasDerivedFrom befree-2016 NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion wasGeneratedBy ECO_0000203 NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.